Learn about our COVID-19 research
Merck clinical trials
Our clinical trials are helping doctors, researchers, and patients learn about possible vaccine and treatment options to help against this global pandemic.
Keep reading to discover how you or a loved one may qualify to take part in one of our clinical trials.
Explore Merck's COVID-19 Clinical Trials
We are enrolling for different types of COVID-19 clinical trials. Choose a trial from the list below that may be right for you.
Clinical trial for adults who have COVID-19 and are not in the hospital
To take part in this trial (MK-4482-002), you must be 18 years or older and:
- Tested positive for the virus causing COVID-19 in the last 5 days
- Have at least 1 COVID-19 sign or symptom when entering the trial such as fever, cough, or loss of taste or smell
- Not be hospitalized or expecting to be in near future
Why take part in a clinical trial?
If you sign up, are qualified and decide to take part:
-
Taking part is voluntary and you are free to stop at any time. Your privacy will be protected throughout the trial.
-
There is no cost to take part and you will receive all trial treatments and trial-related doctor visits at no cost.
-
An experienced trial team will watch your health.
-
Your participation may help researchers learn more about COVID-19 and may help others.
The trial staff at the site will talk with you about other possible risks and benefits of taking part.
About Merck's COVID-19 Research
The COVID-19 pandemic has disrupted everyone’s lives. Our company is one of the select few to continue developing both vaccines and treatments, so we have a special duty to help the global community.
Some of our goals with COVID-19 research are to find treatments that:
- May help patients recover faster
- May reduce COVID-19 symptoms
- Could protect against COVID-19 infection
Help Create Awareness
Know someone who may be interested?
Make a difference and share the word.
